MTB Investment Advisors

MTB Investment Advisors (MTBIA) was a specialized investment management firm and a subsidiary of M&T Bank Corporation. The firm served as the primary investment advisor to the MTB Group of Funds and managed assets for institutional and high-net-worth clients. MTBIA was particularly active in the healthcare and life sciences sectors, employing specialized portfolio managers and analysts to target investments in biotechnology, specialty pharmaceuticals, and medical devices. In January 2012, following M&T Bank's acquisition of Wilmington Trust, the company was rebranded as Wilmington Trust Investment Advisors (WTIA). This transition integrated MTBIA's investment expertise and fund families into the broader Wilmington Trust platform. The firm is notable in the biotech industry for its historical role as a significant institutional investor in early-to-mid-stage healthcare companies.